ClinicalTrials.Veeva

Menu

Significance of the High-risk Hpv Viral Load

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

HPV Infections

Treatments

Other: 2 cervical takings and 2 sampling of blood

Study type

Interventional

Funder types

Other

Identifiers

NCT00682812
2007-30
2007-A01335-48

Details and patient eligibility

About

The aim of this study is to evaluate the significance of an elevated high-risk HPV (HR-HPV) viral load.

Full description

We will particularly evaluate if the HR-HPV viral load:

  • Is correlated to the transcription of the genes of the oncoproteins E6 and E7
  • Is predictive of the integration of the virus in infected cells
  • Is predictive of the presence of HPV in patients' blood
  • Influences the local and systemic immunologic response

Enrollment

149 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The women consulting for the therapeutic care (by hysterectomy or conization) of a LIEHG or a cervical cancer (carcinoma epidermoid or adenocarcinoma) confirmed by the anatomopathologique analysis of a preoperative cervical biopsy.
  • The women having a normal cervix consulting for the surgical care by hysterectomy of a good-hearted pathology of the womb. The normality of the cervix will be confirmed by the anatomopathologique analysis of the detail of hysterectomy
  • The patients participating in this study will have to be of more than 18 years old. All the subjects will be profitable of a regime of Social Security.

Exclusion criteria

  • The patients having a LIEBG
  • The patients incapable to receive the information enlightened on the progress and the objectives of the study
  • The patients not having signed enlightened assent

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

149 participants in 3 patient groups

1
Active Comparator group
Description:
125 womens with normal cervix
Treatment:
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood
2
Other group
Description:
105 womens with an intraepithelial lesion
Treatment:
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood
3
Other group
Description:
105 womens with a cancer of the cervix
Treatment:
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood
Other: 2 cervical takings and 2 sampling of blood

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems